Maravai LifeSciences News

Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)

TipRanksApr 30 08:36 ET

Express News | TriLink BioTechnologies And Lonza Enter Into Non-exclusive License And Supply Agreement For CleanCap MRNA Capping Technology

BenzingaApr 30 07:38 ET

Express News | Trilink Biotechnologies: Trilink Will Supply Patented Cleancap Analogs for Use in Lonza's Global Mrna Development and Manufacturing Services

ReutersApr 30 07:34 ET

Express News | Trilink Biotechnologies® and Lonza Enter Into Non-Exclusive License and Supply Agreement for Cleancap® Mrna Capping Technology

ReutersApr 30 07:31 ET

Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego

Maravai LifeSciences Holdings' (MRVI) TriLink BioTechnologies unit said Thursday that it has opened its new, 32,000-square-foot cGMP mRNA manufacturing facility in San Diego. The facility will use Tri

MT NewswiresApr 18 09:39 ET

Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI)

TipRanksApr 18 09:00 ET

Express News | Trilink Biotechnologies, A Maravai Lifesciences Company Opened A New 32,000 Sq.ft. MRNA Manufacturing Facility

Moomoo 24/7Apr 18 07:37 ET

HROW, HCAT and EGRX Are Among After Hour Movers

Seeking AlphaApr 12 17:05 ET

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024

Maravai LifeSciences, Inc.(Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2024 financial and operating results after the market closes on Wednesday, May 8, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

Maravai LifeSciencesApr 10 16:05 ET

Express News | Craig-Hallum Initiates Coverage On Maravai LifeSciences With Buy Rating, Announces Price Target of $15

Moomoo 24/7Apr 10 08:09 ET

Maravai LifeSciences Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/10/2024 72.61% Craig-Hallum → $15 Initiates Coverage On → Buy 02/23/2024 61.1% RBC Capital $12 → $14 Ma

BenzingaApr 10 08:07 ET

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday.

BenzingaApr 9 10:43 ET

RBC Capital Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)

TipRanksApr 8 21:46 ET

RBC Raises Price Target on Maravai LifeSciences Holdings to $15 From $14, Keeps Outperform Rating

07:50 AM EDT, 04/08/2024 (MT Newswires) -- RBC Raises Price Target on Maravai LifeSciences Holdings to $15 From $14, Keeps Outperform Rating

MT NewswiresApr 8 07:50 ET

Is Maravai LifeSciences Holdings (NASDAQ:MRVI) Using Debt In A Risky Way?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe

Simply Wall StApr 6 09:42 ET

Trending Stocks Today: MicroCloud Hologram Inches up 6.7% Post-Market

April 3rd - US stocks trending post-market.Gainers: $MicroCloud Hologram(HOLO.US)$ up 6.7% to $4.14 with a turnover of $5.87 million. $Intuitive Machines(LUNR.US)$ inches up 5.18% to $6.29 with a turn

moomoo NewsApr 3 18:00 ET

Ford, Envista Holdings, and Alaska Air Are Among Additions to GS' Short Duration List

Seeking AlphaMar 28 13:49 ET

Should You Sell Maravai LifeSciences (MRVI)?

Yahoo FinanceMar 19 07:48 ET

Bio-Techne and Qiagen Had the Biggest Increase in Short Interest Levels Last Month - Baird

Seeking AlphaMar 13 14:01 ET

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the

GlobeNewswireMar 12 16:15 ET